BID and ovarian cancer: The published article titled “Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133+ Ovarian Cancer Stem Cells” has been retracted from Oncology Research, Vol.